Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus FOLFOX4 in Advanced Colorectal Cancer
NCT00813137Phase 2Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Oct 2008
- Primary completion
- Oct 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in colorectal cancer (CRC), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
endostar
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00813137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813137.